[Retracted] Association between lncRNA GAS5, MEG3, and PCAT-1 Polymorphisms and Cancer Risk: A Meta-Analysis

Table 2

Meta-analysis results of the association between rs145204276 and cancer risk.

Variables	Number of studies	del vs. ins		del/del vs. ins/ins		del/del+del/ins vs. ins/ins		del/del vs. ins/ins+del/ins		del/ins vs. ins/ins
		OR (95% CI)		OR (95% CI)		OR (95% CI)		OR (95% CI)		OR (95% CI)
Overall	12	0.95 (0.80, 1.13)^r	0.54	1.09 (0.75, 1.57)^r	0.67	0.97 (0.79, 1.19)^b	0.78	1.02 (0.76, 1.38)^r	0.88	0.94 (0.80,1.100)^r	0.43
Cancer type
Gastric cancer	3	0.79 (0.72, 0.86)^r	0.00	0.90 (0.35, 2.31)^r	0.82	0.88 (0.53, 1.44)^r	0.60	0.74 (0.59, 0.91)^a	0.005	0.84 (0.77, 0.98)^r	0.03
Colorectal cancer	3	0.96 (0.65, 1.40)^r	0.82	0.96 (0.43, 2.16)^r	0.93	0.94 (0.60, 1.45)^r	0.77	0.99 (0.52, 1.87)^r	0.98	0.93 (0.65, 1.34)^r	0.71
Others	6	1.06 (0.82, 1.36)^r	0.68	1.24 (0.72, 2.14)^r	0.93	1.03 (0.76, 1.40)^r	0.84	1.25 (0.81, 1.91)^r	0.31	1.07 (0.97, 1.17)^r	0.16
Ethnicity
Chinese	11	0.98 (0.82, 1.17)^r	0.79	1.15 (0.79, 1.68)^r	0.47	1.01 (0.82, 1.24)^r	0.94	1.06 (0.79, 1.44)^r	0.69	0.96 (0.82, 1.13)^r	0.63
Iran	1	0.61 (0.42, 0.89)^r	—	0.43 (0.17, 1.11)^r	—	0.58 (0.37, 3.91)^r	—	0.51 (0.20, 1.30)^r	—	0.61 (0.38, 0.99)^r	—
Source of controls
PB	10	0.92 (0.76, 1.11)^r	0.38	1.05 (0.70, 1.57)^r	0.80	0.95 (0.76, 1.17)^r	0.62	0.99 (0.71, 1.36)^r	0.93	0.91 (0.78, 1.08)^r	0.28
HB	2	1.10 (0.57, 2.15)^r	0.77	1.30 (0.34, 4.97)^r	0.71	1.12 (0.49, 2.53)^r	0.79	1.23 (0.45, 3.36)^r	0.68	1.09 (0.54, 2.20)^r	0.82
Cancer stage
Stage I+II	7	1.05 (0.86, 1.28)^r	0.62	1.16 (0.80, 1.66)^r	0.44	1.06 (0.81,1.37)^r	0.68	1.18 (0.89, 1.56)^r	0.24	1.01 (0.75 1.36)v^r	0.94
Stage III+IV	7	0.75 (0.50, 1.11)^r	0.15	0.76 (0.35, 1.61)^r	0.47	0.70 (0.44, 1.13)^r	0.14	0.94 (0.54, 1.63)^r	0.82	0.68 (0.43,1.08)^r	0.10

Notes: r: calculating based on a random-effects model.